FDA updates its FAQ on COVID-19 testing and gives EUA to additional tests

On March 28, FDA again updated its FAQ regarding specimen collection for COVID-19 testing.

On March 28, FDA again updated its FAQ regarding specimen collection for COVID-19 testing.

FDA continues to issue additional Emergency Use Authorizations for diagnostic tests for COVID-19 including an additional point-of-care test. As of the morning of March 30, twenty tests now have received EUAs.

FAQs on Diagnostic Testing for SARS-CoV-2

In Vitro Diagnostics EUAs